alzheimer

Grant to study cognitive health in elderly American Indians

SPOKANE, Wash. – Researchers at Washington State University Health Sciences Spokane recently were awarded a $3.655 million four-year grant from the National Institute on Aging to study cognitive health among elderly American Indians.

Illuminating sulfides’ roles in the body

By Will Ferguson, College of Arts & Sciences PULLMAN, Wash. – For the first time, researchers at Washington State University have created an injectable compound or “probe” that illuminates hydrogen sulfide and hydrogen polysulfides in different colors when they are present in cells.

Nasal spray may ease Parkinson’s, other disease symptoms

By Lori Maricle, College of Pharmacy SPOKANE, Wash. – Researchers have reported a 240 percent increase in the brain of the antioxidant glutathione after it is administered via nasal spray. Glutathione deficiency has been documented in a variety of central nervous system disorders, including Parkinson’s disease, multiple sclerosis, autism, Alzheimer’s disease, schizophrenia and bipolar disease.

WSU searches for brain drugs to fight ALS, Alzheimer’s, more

By Lori Maricle, College of Pharmacy SPOKANE, Wash. – Repairing the brain’s “house-cleaning function,” which could help people with Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis (ALS) and 100 other diseases, is the focus of recently funded research at Washington State University.

Student gets award to study old minds with new games

By Ethan Nash, Voiland College of Engineering & Architecture intern PULLMAN, Wash. – A Washington State University computer science student who uses technology to understand cognitive health in the elderly has received a National Science Foundation (NSF) Graduate Research Fellowship.

Dementia drug aiming for clinical trials next year

By Eric Sorensen, WSU science writer SEATTLE – A neurodegenerative disease drug developed at Washington State University will likely qualify for a federal “fast-track” designation and go into clinical trials next year, said Leen Kawas, CEO of M3 Biotechnology Inc.

Volunteers needed for study of memory and dementia

PULLMAN – Volunteers are needed for a new study of memory loss that is getting under way at WSU. The researchers hope to enroll 100 volunteers who are not experiencing memory problems, 50 who are experiencing mild memory problems, and 50 who have been diagnosed with a progressive memory disorder such as Alzheimer’s disease. Participants […]